Journal article

Inhibition and deficiency of the immunoproteasome subunit LMP7 attenuates LCMV-induced meningitis.

  • Mundt S Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Germany.
  • Engelhardt B Theodor Kocher Institute, University of Bern, Bern, Switzerland.
  • Kirk CJ Onyx Pharmaceuticals, South San Francisco, CA, USA.
  • Groettrup M Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Germany.
  • Basler M Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Germany.
  • 2015-10-15
Published in:
  • European journal of immunology. - 2016
English In addition to antigen processing, immunoproteasomes were recently shown to exert functions influencing cytokine production by monocytes and T cells, T-helper cell differentiation, and T-cell survival. Moreover, selective inhibition of the immunoproteasome subunit LMP7 ameliorated symptoms of autoimmune diseases including CD4(+) T-cell mediated EAE. In this study, we show that LMP7 also plays a crucial role in the pathogenesis of lymphocytic choriomeningitis virus (LCMV)-induced meningitis mediated by CTLs. Mice lacking functional LMP7 display delayed and reduced clinical signs of disease accompanied by a strongly decreased inflammatory infiltration into the brain. Interestingly, we found that selective inhibition and genetic deficiency of LMP7 affect the pathogenesis of LCMV-induced meningitis in a distinct manner. Our findings support the important role of LMP7 in inflammatory disorders and suggest immunoproteasome inhibition as a novel strategy against inflammation-induced neuropathology in the CNS.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/33717
Statistics

Document views: 34 File downloads:
  • Full-text: 0